Literature DB >> 8195169

Specific recognition of the blk promoter by the B-lymphoid transcription factor B-cell-specific activator protein.

P Zwollo1, S Desiderio.   

Abstract

Several genes of the src family encode protein-tyrosine kinases that associate with the B-cell antigen receptor complex and are activated upon receptor cross-linking, including blk, lyn, and fyn. The blk gene is the only member of this family whose expression is restricted to B-lymphoid cells. In the B lineage, blk is developmentally regulated: blk transcripts are first detected in pro-B-cells and persist until the differentiation of mature B-cells to plasma cells. We have found that the blk promoter is a target for a specific DNA-binding protein whose activity in B-lymphoid cell lines is positively correlated with blk expression. By three criteria, we have identified this DNA-binding protein as the transcription factor B-cell-specific activator protein (BSAP): 1) oligonucleotides containing known BSAP recognition sites were found to compete specifically with blk for binding to the protein detected in B-lymphoid extracts; 2) authentic BSAP was shown to bind the same site within the blk promoter as the protein identified in B-lymphoid extracts; and 3) the specific DNA-protein complex formed in B-lymphoid extracts was shown to react with an anti-BSAP antiserum. BSAP has been implicated previously in the transcriptional regulation of CD19, whose pattern of expression in B-cell development coincides with that of blk. These observations, and the correlation between expression of BSAP and expression of blk, suggest that BSAP is a positive regulator of blk transcription.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8195169

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  BSAP can repress enhancer activity by targeting PU.1 function.

Authors:  S Maitra; M Atchison
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

2.  B-Lymphoid and myeloid lineages biphenotypic acute leukemia with t(8;21)(q22;q22).

Authors:  Guangsheng He; Depei Wu; Aining Sun; Yongquan Xue; Zhengming Jin; Huiying Qiu; Xiaowen Tang; Miao Miao; Zhengzheng Fu; Xiao Ma; Xiuli Wang; Zixin Chen; Changgeng Ruan
Journal:  Int J Hematol       Date:  2008-02-22       Impact factor: 2.490

3.  Alternative promoters regulate cold inducible RNA-binding (CIRP) gene expression and enhance transgene expression in mammalian cells.

Authors:  Mohamed B Al-Fageeh; C Mark Smales
Journal:  Mol Biotechnol       Date:  2013-06       Impact factor: 2.695

4.  Expression of Pax5 gene in human haematopoietic cells and tissues: comparison with immunodeficient donors.

Authors:  H Kaneko; T Ariyasu; R Inoue; T Fukao; K Kasahara; T Teramoto; E Matsui; S Hayakawa; N Kondo
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

5.  The PAX5 gene: a linkage and mutation analysis in candidate human primary immunodeficiencies.

Authors:  I Vorechovský; S Koskinen; R Paganelli; C I Smith; M Busslinger; L Hammarström
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

6.  DNA-binding and transactivation properties of Pax-6: three amino acids in the paired domain are responsible for the different sequence recognition of Pax-6 and BSAP (Pax-5).

Authors:  T Czerny; M Busslinger
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

7.  Distinct factors regulate the murine RAG-2 promoter in B- and T-cell lines.

Authors:  J Lauring; M S Schlissel
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

8.  MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures.

Authors:  Andrea Zangrando; Marta Campo Dell'orto; Geertruy Te Kronnie; Giuseppe Basso
Journal:  BMC Med Genomics       Date:  2009-06-23       Impact factor: 3.063

9.  Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma.

Authors:  Thorbjørn Krejsgaard; Claudia S Vetter-Kauczok; Anders Woetmann; Hermann Kneitz; Karsten W Eriksen; Paola Lovato; Qian Zhang; Mariusz A Wasik; Carsten Geisler; Elisabeth Ralfkiaer; Juergen C Becker; Niels Ødum
Journal:  Blood       Date:  2009-04-07       Impact factor: 22.113

10.  Development of an isoform-specific gene suppression system: the study of the human Pax-5B transcriptional element.

Authors:  Gilles A Robichaud; Jean-Pierre Perreault; Rodney J Ouellette
Journal:  Nucleic Acids Res       Date:  2008-07-10       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.